
    
      R-CHOP is the standard regimen for patients with diffuse large B-cell lymphoma (DLBCL).
      However, the standard number of cycles is uncertain. Recently, interim PET/CT was found to
      predict prognosis in DLBCL. The hypothesis of this study is to optimize the number of cycles
      based on the interim results of PET/CT in order to avoid treatment exposure.
    
  